Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha1 Anti-Trypsin Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02191839
What this trial is testing

Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery

Who this might be right for
Post Cardiac Surgery Systemic Inflammatory Response
Soroka University Medical Center 20
Not applicableEnded earlyNCT00005098
What this trial is testing

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
National Center for Research Resources (NCRR) 160
Not applicableStudy completedNCT01862211
What this trial is testing

Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort

Who this might be right for
Children With a Deficiency of Alpha-1 Antitrypsin
Hospices Civils de Lyon 296
Large-scale testing (Phase 3)Study completedNCT00460096
What this trial is testing

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05899673
What this trial is testing

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Who this might be right for
Alpha1-Antitrypsin Deficiency
Takeda 31
Testing effectiveness (Phase 2)WithdrawnNCT05146882
What this trial is testing

An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Testing effectiveness (Phase 2)Study completedNCT02168686
What this trial is testing

Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Adverum Biotechnologies, Inc. 6
Not applicableEnrolling By InvitationNCT00884455
What this trial is testing

Alpha-1 Foundation DNA and Tissue Bank

Who this might be right for
Alpha 1 Antitrypsin Deficiency
University of Florida 5,000
Not applicableStudy completedNCT01380626
What this trial is testing

Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha-1-antitrypsin-deficiency
Schön Klinik Berchtesgadener Land 20
Post-approval studies (Phase 4)Looking for participantsNCT07135427
What this trial is testing

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-AntitrypsinCOPDAntibody Deficiency
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Study completedNCT04722887
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 17
Not applicableStudy completedNCT02691611
What this trial is testing

Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
National Jewish Health 39
Not applicableLooking for participantsNCT07152834
What this trial is testing

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

Who this might be right for
Alpha 1-antitrypsin Deficiency (AATD)
Muğla Sıtkı Koçman University 734
Not applicableStudy completedNCT02810327
What this trial is testing

Alpha-1 Carrier Genomics Study

Who this might be right for
Alpha-1 Antitrypsin DeficiencyEmphysemaCOPD+1 more
Medical University of South Carolina 117
Not applicableActive Not RecruitingNCT02014415
What this trial is testing

Alpha-1 Antitrypsin Deficiency Adult Liver Study

Who this might be right for
Alpha-1 Antitrypsin Deficiency
St. Louis University 120
Not applicableStudy completedNCT00499941
What this trial is testing

Alpha-1 Foundation Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Medical University of South Carolina 6,655
Not applicableUnknownNCT02929940
What this trial is testing

Liver Disease in Patients With alpha1-antitrypsin Deficiency

Who this might be right for
alpha1-antitrypsin Deficiency
RWTH Aachen University 500
Not applicableLooking for participantsNCT04157049
What this trial is testing

Alpha-1 Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Alpha-1 Foundation 5,000
Early research (Phase 1)Ended earlyNCT04443192
What this trial is testing

A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects

Who this might be right for
Alpha1 Anti-Trypsin Deficiency
Z Factor Limited 69
Testing effectiveness (Phase 2)Study completedNCT04474197
What this trial is testing

Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype

Who this might be right for
Alpha1-Antitrypsin Deficiency
Vertex Pharmaceuticals Incorporated 44
Next Page